Paul Harmatz is a Gastroenterologist and a Pediatric Gastroenterologist in Oakland, CA. Dr. Harmatz is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome).

Joseph Muenzer is a Pediatrics provider in Chapel Hill, North Carolina. Dr. Muenzer is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), and Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A). Dr. Muenzer is currently accepting new patients.

Barbara Burton is a Medical Genetics specialist and a Pediatrics provider in Chicago, Illinois. Dr. Burton is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Phenylketonuria (PKU), Mucopolysaccharidoses (MPS), and Cholesteryl Ester Storage Disease.

Roberto Giugliani practices in Porto Alegre, Brazil. Mr. Giugliani is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Acid Sphingomyelinase Deficiency (ASMD), Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome), and Bone Marrow Transplant.

Maria Escolar is a Pediatrics provider in Chapel Hill, North Carolina. Dr. Escolar is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), and Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome).

Hiroshi Kobayashi practices in Tokyo, Japan. Mr. Kobayashi is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Pompe Disease, Fabry Disease, and Bone Marrow Transplant.

Anna Szymanska-Tylki practices in Warsaw, Poland. Ms. Szymanska-Tylki is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Gaucher Disease, Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Gaucher Disease Type 1, and Liver Transplant.

Yohta Shimada practices in Tokyo, Japan. Shimada is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Their top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Pompe Disease, GM1 Gangliosidosis, and Bone Marrow Transplant.

Toya Ohashi practices in Chofu, Japan. Ms. Ohashi is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Fabry Disease, Mucopolysaccharidoses (MPS), Pancreaticoduodenectomy, and Bone Marrow Transplant.

Chester Whitley is a Pediatrics specialist and a Medical Genetics provider in Minneapolis, Minnesota. Dr. Whitley is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), and Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A). Dr. Whitley is currently accepting new patients.

Luis Solana-Gutierrez practices in Madrid, Spain. Mr. Solana-Gutierrez is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), PMM2-Congenital Disorder of Glycosylation, and Molybdenum Cofactor Deficiency (MoCD).

Maurizio Scarpa practices in Udine, Italy. Mr. Scarpa is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Non-Langerhans-Cell Histiocytosis, and Heart Transplant.

Takashi Higuchi practices in Minato, Japan. Mr. Higuchi is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Pompe Disease, GM1 Gangliosidosis, and Bone Marrow Transplant.

Brian Bigger practices in Edinburgh, United Kingdom. Mr. Bigger is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Bone Marrow Transplant.

Michael Beck is a primary care provider, practicing in Geriatrics and Internal Medicine in Palos Heights, Illinois. Dr. Beck is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Fabry Disease, Mucopolysaccharidoses (MPS), Gastrostomy, and Carotid Artery Surgery.

Matilde Garcia-Ruiz practices in Mexico City, Mexico. Ms. Garcia-Ruiz is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), ALG1-CDG, Mucopolysaccharidoses (MPS), and Anti-NMDA Receptor Encephalitis.

Raymond Wang is a Medical Genetics provider in Orange, California. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Pompe Disease, and Adenoidectomy.

Lynda Polgreen is a Pediatric Endocrinologist in Orange, California. Dr. Polgreen is rated as a Distinguished provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Osteotomy.

Mari Mori is a Medical Genetics specialist and a Pediatrics provider in Maitland, Florida. Dr. Mori is rated as an Advanced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Glycogen Storage Disease Type 7, FG Syndrome, Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Von Gierke Disease. Dr. Mori is currently accepting new patients.

Dr. Gerald Raymond is a clinical geneticist and neurologist at Johns Hopkins where he is also a professor of genetic medicine and neurology. He obtained his MD at the University of Connecticut and was trained in Pediatrics at Johns Hopkins Hospital and Neurology at the Mass. General Hospital. He received additional training in developmental neuropathology at the Universite Catholique de Louvain in Belgium and clinical genetics at the Harvard Program. Dr. Raymond’s research has been at the overlap of genetics and neurology with specific focus on peroxisomal disorders including adrenoleukodystrophy. He has been actively involved in newborn screening for ALD and in developing clinical follow-up programs. He has extensive experience in clinical management of neurogenetic issues including peroxisomal and lysosomal disorders. He presently serves as the Director of the Lysosomal Storage Disease program in the department of Genetic Medicine. Dr. Raymond is rated as an Advanced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Zellweger Syndrome, and Leukodystrophy.